Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stine Johansen

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Alimentary Pharmacology & Therapeutics|August 11, 2025
MetALD: Diagnosis and Prognosis With Non-Invasive TestsNikolaj Torp, Mads Israelsen, Stine Johansen, et al.
Journal of Hepatology|July 6, 2025
Prevalence, severity and determinants of steatotic liver disease among individuals with metabolic and alcohol risk from the communityCamilla Dalby Hansen, Johanne Kragh Hansen, Mads Israelsen, et al.
Gastroenterology|December 22, 2025
Prognostic Performance of Phosphatidylethanol With Noninvasive Liver Fibrosis Tests in Alcohol-Related Liver DiseaseNikolaj Torp, Stine Johansen, Ellen Lyngbeck Jensen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 14, 2026
Fibrosis progression rate and comparison of paired liver biopsy versus non-invasive tests as surrogate endpoints for clinical trials in MetALD and ALDEllen Lyngbeck Jensen, Maja Thiele, Nikolaj Torp, et al.
JHEP Reports : Innovation in Hepatology|April 5, 2026
Alcohol-Related Liver Disease Disrupts Bile Acid Homeostasis and Gut Microbial Bile Acid MetabolismMarisa Isabell Keller, Andressa de Zawadzki, Maja Thiele, et al.
Annals of Internal Medicine|December 12, 2022
Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease : A Randomized Controlled TrialCamilla Dalby Hansen, Eva-Marie Gram-Kampmann, Johanne Kragh Hansen, et al.
The Lancet. Gastroenterology & Hepatology|December 14, 2024
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort studyKatrine P Lindvig, Katrine H Thorhauge, Johanne K Hansen, et al.
Journal of Hepatology|March 29, 2024
Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseasesMaja Thiele, Ida Falk Villesen, Lili Niu, et al.
Nature Communications|July 2, 2025
The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trialJohanne K Hansen, Mads Israelsen, Suguru Nishijima, et al.
JHEP Reports : Innovation in Hepatology|December 1, 2025
PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort studyAdrià Juanola, Gabriel Mezzano, Elisa Pose, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Alimentary Pharmacology & Therapeutics|August 11, 2025
MetALD: Diagnosis and Prognosis With Non-Invasive TestsNikolaj Torp, Mads Israelsen, Stine Johansen, et al.
Journal of Hepatology|July 6, 2025
Prevalence, severity and determinants of steatotic liver disease among individuals with metabolic and alcohol risk from the communityCamilla Dalby Hansen, Johanne Kragh Hansen, Mads Israelsen, et al.
Gastroenterology|December 22, 2025
Prognostic Performance of Phosphatidylethanol With Noninvasive Liver Fibrosis Tests in Alcohol-Related Liver DiseaseNikolaj Torp, Stine Johansen, Ellen Lyngbeck Jensen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 14, 2026
Fibrosis progression rate and comparison of paired liver biopsy versus non-invasive tests as surrogate endpoints for clinical trials in MetALD and ALDEllen Lyngbeck Jensen, Maja Thiele, Nikolaj Torp, et al.
JHEP Reports : Innovation in Hepatology|April 5, 2026
Alcohol-Related Liver Disease Disrupts Bile Acid Homeostasis and Gut Microbial Bile Acid MetabolismMarisa Isabell Keller, Andressa de Zawadzki, Maja Thiele, et al.
Annals of Internal Medicine|December 12, 2022
Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease : A Randomized Controlled TrialCamilla Dalby Hansen, Eva-Marie Gram-Kampmann, Johanne Kragh Hansen, et al.
The Lancet. Gastroenterology & Hepatology|December 14, 2024
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort studyKatrine P Lindvig, Katrine H Thorhauge, Johanne K Hansen, et al.
Journal of Hepatology|March 29, 2024
Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseasesMaja Thiele, Ida Falk Villesen, Lili Niu, et al.
Nature Communications|July 2, 2025
The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trialJohanne K Hansen, Mads Israelsen, Suguru Nishijima, et al.
JHEP Reports : Innovation in Hepatology|December 1, 2025
PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort studyAdrià Juanola, Gabriel Mezzano, Elisa Pose, et al.
Pageof 4